Prostatic Neoplasms: all 6,484 studies

Page 5 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.

• Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their SpousesRecruitingNCT07196488Not applicable
• A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate CancerRecruitingNCT07192614Phase 1/2
• Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate CancerRecruitingNCT07189598Not applicable
• A Study Looking at a New Nerve Surgery to Help Men Regain Erections After Prostate Cancer SurgeryRecruitingNCT07188064Not applicable
• An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.RecruitingNCT07185165Phase 2
• PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused UltrasoundRecruitingNCT07184970
• Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate CancerRecruitingNCT07184957
• Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate CancerRecruitingNCT07182279Phase 1/2
• A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid TumorsRecruitingNCT07181473Phase 1
• Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate CancerRecruitingNCT07181161Phase 1/2
• Sequential Imaging of Suspicion of Prostate Cancer Reducing Overdiagnosis and Unnecessary Biopsy With Timely Diagnosis of Significant CancerRecruitingNCT07180381Not applicable
• Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)RecruitingNCT07179783Phase 2
• A Study of DXC014 in Patients With Advanced Solid Tumors.RecruitingNCT07177937Phase 1
• Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPCRecruitingNCT07172685Not applicable
• Study of PSMA PET/CT Imaging to Help Select Men With Low-Risk Prostate Cancer for Active SurveillanceRecruitingNCT07168616
• Memantine Hydrochloride in Prostate Cancer PatientsNot yet recruitingNCT07164794Phase 2
• Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON TrialRecruitingNCT07164027Early Phase 1
• Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical StudyRecruitingNCT07163910Phase 2
• Prehabilitation to Patients With Prostate CancerRecruitingNCT07162987Not applicable
• MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER TrialRecruitingNCT07162194Not applicable
• A Digitally Distributed Yoga Intervention in Prostate Cancer Rehabilitation : Protocol for a Randomized Controlled TrialNot yet recruitingNCT07158138Not applicable
• Stereotactic Focal Radiotherapy as an Alternative Treatment to Active Surveillance for Low and Intermediate Risk Prostate CancerNot yet recruitingNCT07152067Phase 2
• A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese AdultsRecruitingNCT07149831Phase 1
• Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prostate Cancer (PROSTERA)Not yet recruitingNCT07145437Not applicable
• Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid TumorsRecruitingNCT07145255Phase 1/2
• 177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate CancerRecruitingNCT07145177Phase 1
• Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate CancerRecruitingNCT07144228
• Supraphysiologic Testosterone Priming Induces Darolutamide Extended ResponseRecruitingNCT07142551Phase 2
• Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate CancerRecruitingNCT07140900Phase 1
• Identifying Fundamental Mechanisms of Skeletal Muscle Ageing in Older Men Undergoing Androgen Deprivation Therapy: a Feasibility StudyNot yet recruitingNCT07134439
• MRI-guided Brachytherapy and Salvage SBRT ProgramNot yet recruitingNCT07132671Not applicable
• MRI-guided Ultrahypofractionated SBRT Prostate ProgramNot yet recruitingNCT07132658Not applicable
• MRI-guided Locoregional SBRT Prostate ProgramEnrolling by invitationNCT07132073Not applicable
• Immune Biomarkers in Prostate Cancer Patients Treated With BrachytherapyRecruitingNCT07131956
• Exploring the Potential of Robotic Telesurgery in Remote SettingsRecruitingNCT07130708Not applicable
• Navigation, Outcomes and Quality-of-life in Prostate Cancer Patients Undergoing PSMA-targeted SurgeryRecruitingNCT07129551Not applicable
• A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black MenRecruitingNCT07126548Not applicable
• High-intensity Focused Ultrasound Combined With Novel Hormone Therapy in Advanced Prostate CancerNot yet recruitingNCT07126093Not applicable
• DESTINY-PANTUMOUR04RecruitingNCT07124000
• Liquid Biopsy Under PSMA Radioligand TherapyRecruitingNCT07118436
• Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended Pelvic Lymph Node Dissection for Localized Intermediate- and High-risk Prostate Cancer With a Briganti Nomogram≥7%RecruitingNCT07115992Not applicable
• PSMA PET for Surveillance After Focal TherapyRecruitingNCT07115914Not applicable
• Diagnostic Efficacy and Safety of Flotufolastat F-18 Injection in Subjects With Biochemical Recurrence of Prostate CancerRecruitingNCT07115277Not applicable
• A Study of LY4257496 in Participants With Cancer (OMNIRAY)RecruitingNCT07114601Phase 1
• Feasibility Trial of Single-Dose Radiotherapy for Localized Low and Intermediate Risk Prostate CancerRecruitingNCT07112781Not applicable
• Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate CancerNot yet recruitingNCT07112612
• Study of Predicting Lymph Node Metastasis of High-risk Prostate Cancer by Artificial Intelligence Multi-omics AnalysisRecruitingNCT07112599
• A Study of Tarlatamab for People With Prostate CancerRecruitingNCT07111507Phase 2
• Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health SystemRecruitingNCT07109427Not applicable
• iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate CancerNot yet recruitingNCT07105020Not applicable
• Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate CancerNot yet recruitingNCT07104110Phase 1/2
• A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)RecruitingNCT07103018Phase 1
• SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) TherapyRecruitingNCT07096999
• Prostate Cancer Study of Patient ExperiencesNot yet recruitingNCT07096596
• Multimodal Telerehabilitation of Rural Patients With Advanced Prostate CancerRecruitingNCT07093177Not applicable
• Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate CancerNot yet recruitingNCT07090369Phase 1
• Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPCRecruitingNCT07090148Phase 1
• Occupational Situation and Return to Work of Urological PatientsRecruitingNCT07088536
• Investigation of Impact of AI on Prostate Cancer WorkflowRecruitingNCT07084779Not applicable
• A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate CancerRecruitingNCT07082920Phase 1
• Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing ToxicityRecruitingNCT07077239
• Transperineal Micro-ultrasound for the Detection of Prostate Cancer During BiopsyRecruitingNCT07075705Not applicable
• Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate CancerRecruitingNCT07073794Phase 2
• Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment DisorderRecruitingNCT07072728Phase 2
• Effect of Text Message Reminders on M-ISI Score After Prostate SurgeryRecruitingNCT07071207Not applicable
• Electroacupuncture in the Treatment of Patients Undergoing Transperineal Prostate Biopsy Under Local AnesthesiaNot yet recruitingNCT07069049Not applicable
• Standardized Resistance Training Program and Assessment System for Prostate Cancer Patients Receiving Androgen Deprivation Therapy ISPoRT-PCa-ADT Study Protocol for a Randomized Controlled Trial. SPORT-MUNot yet recruitingNCT07064811Not applicable
• Distance-Based Exercise to Preserve Function and Prevent DisabilityRecruitingNCT07059884Not applicable
• The Effect of Pulsed Electromagnetic Field Therapy on Muscle Mass and Muscle Strength in Prostate Cancer Patients Treated With Androgen Deprivation TherapyRecruitingNCT07057375Not applicable
• Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and Restaging of Prostate CancerRecruitingNCT07056790Phase 1/2
• Connect2Care: Prostate Cancer Education and Screenings for African American MenRecruitingNCT07055165Not applicable
• Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617RecruitingNCT07054346Phase 1
• Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDerationRecruitingNCT07052578
• COMPASS Study for Metastatic Castration-resistant Prostate CancerRecruitingNCT07050433
• Stem Cells for Erectile Dysfunction Post RALPRecruitingNCT07048314Phase 1/2
• Personalization of External Beam Radiation Therapy in Localised TumoursRecruitingNCT07047495
• The Effect of Pelvic Floor Muscle Exercises After Radical ProstatectomyNot yet recruitingNCT07045415Not applicable
• Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Localized Prostate CancerRecruitingNCT07042256Not applicable
• The Florida ASCENT StudyRecruitingNCT07042243Not applicable
• Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AINot yet recruitingNCT07040501Not applicable
• The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)RecruitingNCT07038304Phase 2
• Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate CancerRecruitingNCT07032584Not applicable
• Evaluation of the Efficacy of Darolutamide Triplet Therapy in Patients With Metastatic Hormone-sensitive Prostate CancerNot yet recruitingNCT07031258
• This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.RecruitingNCT07028853Phase 3
• Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate CancerRecruitingNCT07027124Phase 2
• Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA TrialRecruitingNCT07025369Phase 2
• Study of ZG006 in Participants With Neuroendocrine Prostate CancerNot yet recruitingNCT07024277Phase 2
• Creative Arts Therapy on Body Image, Self-esteem, Anxiety and Depression in Post-Treatment Prostate Cancer PatientsNot yet recruitingNCT07015866Not applicable
• Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate CancerRecruitingNCT07015138Not applicable
• Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate CancerRecruitingNCT07014618
• Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland TreatmentRecruitingNCT07011342Not applicable
• Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate CancerRecruitingNCT07007910Phase 1
• A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate CancerRecruitingNCT07005154Phase 2
• Lab Research Using Mini-tumors to Study Prostate Cancer TreatmentsRecruitingNCT07004582
• Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate CancerRecruitingNCT07002320Phase 1/2
• Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study)RecruitingNCT07001709Phase 4
• Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer SurvivorsRecruitingNCT07001241Phase 2
• The Vanguard Study: Testing a New Way to Screen for CancerRecruitingNCT06995898Not applicable
• Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPCRecruitingNCT06992232Phase 2
• A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate CancerRecruitingNCT06990880Phase 1/2

← Prostatic Neoplasms overview